Page last updated: 2024-10-29

indomethacin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

indomethacin has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 4 studies

Indomethacin: A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES.
indometacin : A member of the class of indole-3-acetic acids that is indole-3-acetic acid in which the indole ring is substituted at positions 1, 2 and 5 by p-chlorobenzoyl, methyl, and methoxy groups, respectively. A non-steroidal anti-inflammatory drug, it is used in the treatment of musculoskeletal and joint disorders including osteoarthritis, rheumatoid arthritis, gout, bursitis and tendinitis.

Research Excerpts

ExcerptRelevanceReference
" In this study, we evaluated the changes on serum 2'5'-oligoadenylate synthetase levels induced by acute administration of interferon-alpha, indomethacin and interferon-alpha plus indomethacin in 21 patients with hepatitis B or C virus chronic active hepatitis."7.69Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis. ( Andreone, P; Buzzi, A; Cursaro, C; Gasbarrini, G; Gramenzi, A; Miniero, R; Sprovieri, G, 1994)
"We evaluated the effect of ursodeoxycholic acid on the defective natural killer activity in primary biliary cirrhosis."7.69Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis. ( Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H, 1996)
" In this study, we evaluated the changes on serum 2'5'-oligoadenylate synthetase levels induced by acute administration of interferon-alpha, indomethacin and interferon-alpha plus indomethacin in 21 patients with hepatitis B or C virus chronic active hepatitis."3.69Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis. ( Andreone, P; Buzzi, A; Cursaro, C; Gasbarrini, G; Gramenzi, A; Miniero, R; Sprovieri, G, 1994)
"We evaluated the effect of ursodeoxycholic acid on the defective natural killer activity in primary biliary cirrhosis."3.69Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis. ( Moriwaki, H; Muto, Y; Nishigaki, Y; Ohnishi, H, 1996)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's1 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreone, P1
Cursaro, C1
Gramenzi, A1
Buzzi, A1
Miniero, R1
Sprovieri, G1
Gasbarrini, G1
Nishigaki, Y1
Ohnishi, H1
Moriwaki, H1
Muto, Y1
Bruguera, M1
Zullo, A1
Fanfarillo, F1
Winn, S1
Delfino, M1
Cascino, A1
Baratta, L1

Reviews

1 review available for indomethacin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
[Treatment of chronic hepatitis C: still many problems pending].
    Gastroenterologia y hepatologia, 1997, Volume: 20, Issue:1

    Topics: Adrenal Cortex Hormones; Aged; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antiv

1997

Other Studies

3 other studies available for indomethacin and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted

ArticleYear
Indomethacin enhances serum 2'5'-oligoadenylate synthetase in patients with hepatitis B and C virus chronic active hepatitis.
    Journal of hepatology, 1994, Volume: 21, Issue:6

    Topics: 2',5'-Oligoadenylate Synthetase; Adolescent; Adult; Drug Combinations; Female; Hepatitis Antibodies;

1994
Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
    Digestive diseases and sciences, 1996, Volume: 41, Issue:7

    Topics: Adult; Aged; Cells, Cultured; Chenodeoxycholic Acid; Cholic Acid; Cholic Acids; Chronic Disease; Deo

1996
HCV hepatitis and polyarthritis: a therapeutic approach.
    Journal of clinical gastroenterology, 2000, Volume: 30, Issue:2

    Topics: Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Infectious; Hepatitis C; Humans; Indomethacin; M

2000